CCR Grand Rounds - Personalized Cellular Therapy for Cancer

CCR Grand Rounds Antoni Ribas, M.D., Ph.D. is Professor of Medicine, Professor of Surgery, and Professor of Molecular and Medical Pharmacology at the University of California Los Angeles (UCLA), Director of the Tumor Immunology Program at the Jonsson Comprehensive Cancer Center (JCCC), Director of the Parker Inst itute for Cancer Immunotherapy (PICI) Center at UCLA. Dr Ribas is a physician-scientist who conducts laboratory and clinical research in malignant melanoma, focusing on gene engineered T cells, PD-1 blockade and BRAF targeted therapies. His National Cancer Institute (NCI), State of California and fo undation-supported research laboratory studies mechanism of action of treatments and therapy response and resistance. He has been instrumental in the clinical development of several agents approved by the FDA, including pembrolizumab (Keytruda), tremelimumab (Imjudo), axicabtagene ciloleucel (Yescar ta), vemurafenib (Zelboraf), cobimetinib (Cotellic), dabrafenib (Tafinlar) and trametinib (Mekinist). He is the recipient of AACR Richard and Hinda Rosenthal Award, William B. Coley Award from Cancer Research Institute (CRI), AACR-CRI Lloyd J. Old Award in Cancer Immunology, two NCI Outstanding Investigator Awards, awarded a Doctor Honoris Causa from the University of Buenos Aires and the Free University of Brussels, profiled as one of the five Visionaries in Medicine by the New York Times (May 27, 2018) and Great Immigrant by the Carnegie Foundation. He is past-president of...
Source: Videocast - All Events - Category: General Medicine Tags: Upcoming Events Source Type: video